Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients?

dc.contributor.authors	Erten C, Demir L, Somali I, Alacacioglu A, Kucukzeybek Y, Akyol M, Can A, Dirican A, Bayoglu V, Tarhan MO
dc.date.accessioned	2020-02-27T08:36:15Z
dc.date.available	2020-02-27T08:36:15Z
dc.date.issued	2013
dc.identifier.citation	Erten C, Demir L, Somali I, Alacacioglu A, Kucukzeybek Y, Akyol M, Can A, Dirican A, Bayoglu V, Tarhan MO (2013). Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients? . Asian Pac J Cancer Prev., 14(6), 7-3711
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66524
dc.title	Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients?
dc.identifier.volume	14(6)
dc.identifier.startpage	3711
dc.identifier.endpage	7
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Asian Pac J Cancer Prev.
dc.contributor.author	Bayoğlu, İbrahim Vedat